YesAsia Holdings Limited (HKG:2209)

Ligand Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	15.53	25.18	18.8	36.47	28.48
Cash & Short-Term Investments	15.53	25.18	18.8	36.47	28.48
Cash Growth	-38.33%	33.96%	-48.45%	28.02%	67.63%
Accounts Receivable	9.97	5.86	2.15	1.82	2.55
Other Receivables	0.01	0.05	0.58	0.4	0.02
Receivables	9.98	5.91	2.73	2.23	2.57
Inventory	55.1	20.85	11.9	7.59	8.36
Prepaid Expenses	5.97	3.02	3.67	3.92	3.31
Other Current Assets	2.93	1.26	3.18	2	2.45
Total Current Assets	89.5	56.22	40.27	52.21	45.18
Property, Plant & Equipment	22.82	12.35	16.8	13.52	15.01
Long-Term Investments	1.4	1.73	2.03	2.24	0.78
Other Intangible Assets	1.99	2.56	2.93	1.16	1.16
Other Long-Term Assets	4.86	1.62	1.7	0.76	1.25
Total Assets	120.57	74.49	63.72	69.89	63.38
Accounts Payable	9.93	5.83	4.14	5.33	8.54
Accrued Expenses	12.23	6.44	5.17	4.17	5.33
Short-Term Debt	-	-	-	-	0.49
Current Portion of Leases	8.15	4.72	3.9	3.63	3.76
Current Income Taxes Payable	3.52	0.43	0.08	0.61	1.9
Current Unearned Revenue	16.26	12.74	9.39	9.3	8.44
Other Current Liabilities	0.9	0.71	1.7	1.04	1.74
Total Current Liabilities	50.98	30.86	24.38	24.08	30.2
Long-Term Leases	14.66	7.47	11.56	9.13	10.22
Other Long-Term Liabilities	1.94	1.1	0.64	0.39	0.5
Total Liabilities	67.58	39.43	36.59	33.6	40.92
Common Stock	24.18	20.64	20.49	20.48	2.31
Retained Earnings	11.67	-4.89	-12.47	-3.13	1.49
Comprehensive Income & Other	17.15	19.31	19.11	18.93	18.65
Total Common Equity	53	35.06	27.14	36.29	22.45
Minority Interest	-0.01	-0	-	-	-
Shareholders' Equity	52.99	35.05	27.14	36.29	22.45
Total Liabilities & Equity	120.57	74.49	63.72	69.89	63.38
Total Debt	22.8	12.18	15.46	12.76	14.47
Net Cash (Debt)	-7.28	13	3.33	23.71	14.01
Net Cash Growth	-	289.95%	-85.94%	69.20%	0.73%
Net Cash Per Share	-0.02	0.03	0.01	0.09	0.04
Filing Date Shares Outstanding	409.71	397.12	395.96	395.91	179.87
Total Common Shares Outstanding	409.71	397.12	395.96	395.91	164.34
Working Capital	38.52	25.35	15.89	28.13	14.98
Book Value Per Share	0.13	0.09	0.07	0.09	0.14
Tangible Book Value	51.01	32.49	24.21	35.13	21.29
Tangible Book Value Per Share	0.12	0.08	0.06	0.09	0.13
Machinery	1.26	1.16	1.3	1.28	0.68
Leasehold Improvements	3.5	3.44	3.46	2.14	1.66

Updated Aug 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.